We at Hyundai Bioland will give our all in our business activities to expand the values of our shareholders and stakeholders.
Category | Type of stock | 27th term (2021) |
26th term (2020) |
25th term (2019) |
24th term (2018) |
23th term (2017) |
---|---|---|---|---|---|---|
Par value per share (KRW) |
500 | |||||
(Consolidated) Net income (KRW 1 mil.) |
-11,686 | -13,545 | 10,849 | 15,047 | 11,979 | |
(Separate) Net income (KRW 1 mil.) |
-6,423 | -11,813 | 9,568 | 13,554 | 11,807 | |
(Consolidated) Earnings per share (KRW) |
-779 | -903 | 723 | 1,003 | 799 | |
Total cash dividends (KRW 1 mil.) |
1,050 | 1,500 | 5,250 | 4,500 | 3,750 | |
Total stock dividend (KRW 1 mil.) |
- | |||||
(Consolidated) Cash dividend payout ratio (%) |
9.0 | 11.1 | 48.4 | 29.9 | 31.3 | |
Cash dividend yield (%) |
Common stock | 0.4 | 0.4 | 1.7 | 2.0 | 1.3 |
Preferred stock | - | |||||
Cash dividend per share (KRW) |
Common stock | 70 | 100 | 350 | 300 | 250 |
Preferred stock | - |
※ As per the approval of the Board of Directors on electronic voting on March 5, 2020, our company is operating the electronic voting system it established.